Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Non-Current Liabilities (2016 - 2017)

Cytosorbents filings provide 4 years of Other Non-Current Liabilities readings, the most recent being $1.0 million for Q2 2017.

  • On a quarterly basis, Other Non-Current Liabilities fell 42.13% to $1.0 million in Q2 2017 year-over-year; TTM through Jun 2017 was $1.0 million, a 42.13% decrease, with the full-year FY2016 number at $1.8 million, up 10.72% from a year prior.
  • Other Non-Current Liabilities hit $1.0 million in Q2 2017 for Cytosorbents, down from $1.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.0 million in Q4 2014 to a low of $1.0 million in Q2 2017.
  • Median Other Non-Current Liabilities over the past 4 years was $1.7 million (2016), compared with a mean of $1.9 million.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 45.12% in 2015 and later increased 10.72% in 2016.
  • Cytosorbents' Other Non-Current Liabilities stood at $3.0 million in 2014, then tumbled by 45.12% to $1.6 million in 2015, then increased by 10.72% to $1.8 million in 2016, then tumbled by 42.23% to $1.0 million in 2017.
  • The last three reported values for Other Non-Current Liabilities were $1.0 million (Q2 2017), $1.7 million (Q1 2017), and $1.8 million (Q4 2016) per Business Quant data.